These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2209837)

  • 41. Proglumide, a gastrin receptor antagonist, inhibits growth of colon cancer and enhances survival in mice.
    Beauchamp RD; Townsend CM; Singh P; Glass EJ; Thompson JC
    Ann Surg; 1985 Sep; 202(3):303-9. PubMed ID: 2994583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colorectal carcinoma: prognostic significance of gastrin.
    Anand A; Anand A
    J Natl Cancer Inst; 1995 Jul; 87(14):1086. PubMed ID: 7616602
    [No Abstract]   [Full Text] [Related]  

  • 43. Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
    Halama N; Zoernig I; Berthel A; Kahlert C; Klupp F; Suarez-Carmona M; Suetterlin T; Brand K; Krauss J; Lasitschka F; Lerchl T; Luckner-Minden C; Ulrich A; Koch M; Weitz J; Schneider M; Buechler MW; Zitvogel L; Herrmann T; Benner A; Kunz C; Luecke S; Springfeld C; Grabe N; Falk CS; Jaeger D
    Cancer Cell; 2016 Apr; 29(4):587-601. PubMed ID: 27070705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Blood transfusion worsens the prognosis in colorectal cancer. Preliminary study in a series of 717 cases].
    Pellicer Franco EM; García Olmo D; Parrilla Paricio P; Morales Cuenca G; Prieto A
    Rev Esp Enferm Dig; 1990 Mar; 77(3):189-92. PubMed ID: 2378757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug development in pancreatic cancer: finally, biology begets therapy.
    Cohen SJ; Meropol NJ
    Int J Gastrointest Cancer; 2002; 32(2-3):91-106. PubMed ID: 12794245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical uses of gut peptides.
    Geoghegan J; Pappas TN
    Ann Surg; 1997 Feb; 225(2):145-54. PubMed ID: 9065291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Personal experience on treatment of colorectal liver metastases: a multidisciplinary approach.
    Mancini R; Ettorre G; Vennarecci G; Sperduti I; Garufi C; Esposito A; Cosimelli M
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):213-7. PubMed ID: 16767934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colorectal cancer metastases: surgical indications and multimodal approach.
    Ciferri E; Bondanza GS; Municinò O; Castagnola M; Gazzaniga GM
    Hepatogastroenterology; 2003; 50(54):1836-46. PubMed ID: 14696416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome.
    Hamady ZZ; Malik HZ; Alwan N; Wyatt JI; Prasad KR; Toogood GJ; Lodge JP
    Eur J Surg Oncol; 2008 Feb; 34(2):180-4. PubMed ID: 17983724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The chemoradiotherapy of advanced colorectal carcinoma--the results and toxicity in a pilot study with 44 patients].
    Brockmann WP; Wiegel T; Sommer K; Steiner P; Hübener KH
    Strahlenther Onkol; 1993 Feb; 169(2):107-13. PubMed ID: 8451725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pilot randomized control trial of proglumide (a gastrin receptor antagonist) in advanced colorectal cancer.
    Morris DL; Charnley RM; Ballantyne KC; Jones J
    Eur J Surg Oncol; 1990 Oct; 16(5):423-5. PubMed ID: 2209837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver metastases of colorectal cancer: medical treatments.
    Pasetto LM; Rossi E; Monfardini S
    Anticancer Res; 2003; 23(5b):4245-56. PubMed ID: 14666634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
    Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y
    Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Excisional surgery of hepatic metastases of colorectal adenocarcinoma].
    Pouyet M; Baulieux J; Ducerf C; Caillon P
    J Chir (Paris); 1988 Oct; 125(10):565-70. PubMed ID: 3068234
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.